- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic, Gastric or Gastro-oesophageal Junction, Cancer in India
Total 41 results
-
AstraZenecaTerminatedGastric Cancer | Gastro-oesophageal Junction CancerBulgaria, Czech Republic, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Romania, Ukraine, Belgium, Canada, Germany, Taiwan, India, Japan, France
-
Asian Institute of Gastroenterology, IndiaCompletedGastro Esophageal Reflux DiseaseIndia
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Asian Institute of Gastroenterology, IndiaRecruitingGastric Varices BleedingIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingHigh Risk Esophageal VaricesIndia
-
Asian Institute of Gastroenterology, IndiaRecruitingGastric RefluxIndia
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Govind Ballabh Pant HospitalUnknown
-
Institute of Liver and Biliary Sciences, IndiaUnknown
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Govind Ballabh Pant HospitalCompletedCirrhosis | Portal Hypertension | Acute Bleeding Esophageal VaricesIndia
-
Institute of Liver and Biliary Sciences, IndiaRecruiting
-
Govind Ballabh Pant HospitalCompleted
-
Hospital del Río HortegaComplejo Hospitalario de Navarra; Clinica Universidad de Navarra, Universidad... and other collaboratorsCompletedGastric Cancer | Pancreatic Cancer | Gastric Outlet ObstructionSpain, India
-
Institute of Liver and Biliary Sciences, IndiaCompletedCirrhosis With Esophageal VaricesIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute-On-Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute on Chronic Liver FailureIndia
-
Tata Memorial HospitalUnknown
-
Tata Memorial HospitalTerminated
-
Tata Memorial CentreRecruiting
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Netherlands, Spain, Japan, China, Germany, United Kingdom, Malaysia, Taiwan, Portugal, France, Italy, Australia, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Singapore, Poland and more
-
Aurigene Discovery Technologies LimitedRecruitingKidney Cancer | Gastric Cancer | Non Small Cell Lung Cancer | Colon Cancer | Urothelial Carcinoma | Relapse | Esophagus Cancer | Advanced Malignant NeoplasmIndia
-
Hoffmann-La RocheTerminated
-
National University Hospital, SingaporePrince of Wales Hospital, Shatin, Hong Kong; Apollo Gleneagles Hospitals, KolkataUnknownGastric Cancer | Colon CancerSingapore, India, China
-
Asian Institute of Gastroenterology, IndiaRecruitingDiabetes Complications | Dyspepsia | Gastroparesis | Idiopathic Gastric Motility DisorderIndia
-
Thrombosis Research InstituteCompletedGastric Cancer | Gastroesophageal CancerIndia
-
AB ScienceCompletedLocally Advanced or Metastatic Pancreatic CancerFrance, Belgium, Greece, India, Russian Federation, Slovakia, Tunisia, Ukraine
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands
-
Sun Pharma Advanced Research Company LimitedCompletedRecurrent or Metastatic Breast CancerIndia
-
Hoffmann-La RocheChugai PharmaceuticalCompletedGastric CancerBelgium, France, Italy, Spain, China, Costa Rica, Denmark, Germany, Portugal, Taiwan, United Kingdom, Russian Federation, Korea, Republic of, Peru, Turkey, Mexico, Australia, Brazil, Finland, Guatemala, India, Japan, Panama, South Africa
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Poland, Colombia, India, Oman, Uganda, United Arab... and more
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Spain, Denmark, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, India, Poland, Sweden, Italy
-
National Cancer Institute (NCI)Karolinska Institutet; Vanderbilt University Medical Center, USA; New England... and other collaboratorsTerminatedGastric Cancer | Intestinal Metaplasia | Non-Atrophic GastritisSpain, Lithuania, Taiwan, Singapore, Argentina, Korea, Republic of, Sweden, Canada, United States, Peru, Puerto Rico, Mexico, Chile, Turkey, Belgium, Kenya, Malaysia, Vietnam, Colombia, Israel, Brazil, Nepal, Switzerland, Japan, Congo,... and more
-
Eli Lilly and CompanyCompletedAdenocarcinoma | Gastric CancerUnited States, Canada, Brazil, Czechia, Egypt, Korea, Republic of, Lebanon, Poland, Russian Federation, Spain, Romania, United Kingdom, Australia, Croatia, Italy, Philippines, Thailand, Argentina, Bosnia and Herzegovina, Chile, ... and more
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, United States, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom